Cancer research
A recent study published in Clinical Lung Cancer has investigated the real-world treatment response and outcomes of first-line nivolumab and ipilimumab plus chemotherapy (NIC) versus pembrolizumab plus chemotherapy (PC) in patients with PD-L1 negative metastatic non-small cell lung cancer (mNSCLC). The study, conducted at the St. Antonius Hospital in Utrecht,
Cancer research
Research from the Center for Cancer Biology at the University of South Australia has demonstrated the potential of Zirconium-89-labeled APOMAB to detect immune-mediated tumour cell death in vivo. The study, published in the Journal of Translational Medicine, found that APOMAB-immunoPET showed increased tumour uptake of 89Zirconium-labelled APOMAB after CAR-T cell
Cancer research
Researchers from the University of Michigan have published a groundbreaking study demonstrating that the combination of olaparib and radiotherapy can sensitize pancreatic cancer to immunotherapy. The study, which has been peer-reviewed and published in Molecular Cancer Therapeutics, reveals that the combination treatment enhances type I interferon (T1IFN)-mediated immune signaling,
Cancer research
Research conducted by the H. Lee Moffitt Cancer Center and Research Institute has revealed the mechanisms underlying the immunosuppressive ability of neutrophils in brain tumors. The study found that hypoxia drives histone lactylation, which regulates arginase-1 expression, required for T-cell suppression. This study identifies histone lactylation as a potential therapeutic
Cancer research
Research from Wuhan University of Science and Technology in Xiangyang, People's Republic of China, has shed light on the challenges and opportunities in treating non-small cell lung cancer (NSCLC) that has a Kirsten rat sarcoma viral oncogene homolog (KRAS) mutation. The study highlights the potential of immunomodulatory therapy
Cancer research
A large population-based cohort study using data from the US National Cancer Database (NCDB) has found that immunotherapy use increased significantly for metastatic head and neck squamous cell carcinoma (mHNSCC) treatment from 2013 to 2020. The study, led by researchers from the University of Pennsylvania, analyzed data from over 5,
Cancer research
Tianjin Medical University Cancer Institute and Hospital researchers have made a significant discovery in the field of thyroid cancer by developing a novel classifier and prognostic model based on the stemness characteristics of thyroid cancer patients. Utilizing transcriptomic data from The Cancer Genome Atlas (TCGA) database, the team identified three
Cancer research
Researchers from Southwest Medical University have developed a novel prognostic model for lung adenocarcinoma (LUAD) that takes into account telomere-associated genes (TRGs). The study, published in Discover Oncology, aimed to investigate the impact of TRGs on immunotherapy and clinical prognosis prediction in LUAD. The research team found that TRGs were
Cancer research
Air pollution has been shown to have a significant impact on the genetic code of lung tumors, driving DNA mutations that are commonly associated with tobacco smoking. A study of 871 never-smoking lung cancer patients from Europe, North America, Africa, and Asia found a strong link between air pollution levels
Cancer research
Researchers at Vanderbilt University have made a groundbreaking discovery that dipeptidase-1 (DPEP1) is highly upregulated in colorectal cancer (CRC), with its enzymatic function linked to invasion and metastasis. This study has significant implications for our understanding of the mechanisms underlying CRC and its relationship with the tumor microenvironment. The research
Cancer research
Researchers from Memorial Sloan-Kettering Cancer Center have made a groundbreaking discovery in the fight against colorectal cancer. A new study has outlined the efficacy and safety of a novel radioimmunotherapy approach, providing new hope for patients suffering from this devastating disease. The research team has successfully developed a three-step pretargeted
Cancer research
Research has shed new light on the complex relationship between chemoradiotherapy (CRT) and immunotherapy in locally advanced non-small-cell lung cancer (LA-NSCLC) patients. A recent study published in View journal revealed that circulating genomic biomarkers can predict chemoradiotherapy resistance and immunotherapy response in LA-NSCLC patients. Key Takeaways: * The study analyzed longitudinal
